[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Priyanka Sharma\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100562471","her2-positive-breast-cancer-registry-100562471",false,"NCT06603597","HER2-positive Breast Cancer Registry","Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)","PRO-HER2","Inclusion Criteria:\n\n* Stage I-IV HER2-positive breast cancer\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":20,"type":21},1000,"ESTIMATED","10 Years","OBSERVATIONAL","The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.",[26],"HER2 + Breast Cancer",[28,29,30,31],"breast cancer","registry","HER2+","HER2 positive","RECRUITING","2025-09-02",{"date":35,"type":36},"2025-09-10","ACTUAL",{"date":38,"type":36},"2024-09-27",{"date":40,"type":21},"2044-10",{"name":42,"class":43},"Priyanka Sharma","OTHER",6,""]